Alemtuzumab | m-entrepreneurship.com

Product Name :
Alemtuzumab

Search keywords :
Alemtuzumab

drugId :
null

Target Vo:
CAMPATH-1 antigen

Target Vo Short Name :
CD52

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :
United States

First Approval Date Filter:
2001

Origin Company_Name :
Genzyme Corp

Active Company_Name :
Genzyme Corp

Active Indication_Name:
Leukemia, Lymphocytic, Chronic, B-Cell

In Active Indication_Name:
Sezary Syndrome

Termination Status :

China Termination Status :
Phase 2 Clinical

Highest Status:
Approved

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MLH1 (YP7041) Mouse mAb Autophagy
Phospho-ATM (S1981) Rabbit mAb Protocol
Phospho-c-Myc(Ser62) Antibody: Phospho-c-Myc(Ser62) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Phospho-c-Myc(S62). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts